Medical News

RSS

Somaxon prices underwritten public offering of common stock

Somaxon Pharmaceuticals, Inc. today announced that it has priced an underwritten public offering of 8,800,000 shares of its common stock at a price to the public of $2.95 per share. The offering is expected to close on or about November 24, 2010, subject to customary closing conditions.

19 Nov 2010

Medtronic's Valiant Stent System effective for thoracic aortic aneurysms treatment

An implantable medical device used in the minimally invasive treatment of thoracic aortic aneurysms, the Valiant Thoracic Stent Graft System from Medtronic, Inc., delivered strong results through 30 days of patient follow-up in the company's U.S. pivotal study, according to clinical data presented at VEITHsymposium.

19 Nov 2010

State roundup: California PPOs 'low marks'; Geriatric nursing; Physician shortages

News outlets covered a range of developments including workforce issues in Minnesota and California, and a Kentucky order for insurers to provide child-only policies.

19 Nov 2010

PSS World Medical enters definitive agreement to acquire Linear

PSS World Medical, Inc. announced today that it has entered into a definitive agreement to acquire Jacksonville, Florida-based Linear Solutions, Inc.

19 Nov 2010

Political cartoon: Mayberry R.F.D.?

Kaiser Health News provides a political cartoonist's perspective on health policy developments with "Mayberry R.F.D.?" by Eric Allie.

19 Nov 2010

U.S. falling short of its goals to improve access to clean water, sanitation worldwide, report says

The U.S. is falling short on its goal of improving conditions for the 2.6 billion people worldwide without access to clean water and sanitation despite the fact the Water for the Poor Act became law in 2005, according to a report released Thursday by the Natural Resources Defense Council (NRDC), WaterAid, CARE and 11 other organization, Food Safety News reports.

19 Nov 2010

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

The U.S. Food and Drug Administration approved Xgeva (denosumab) on Thursday to help prevent skeletal-related events (SREs) in patients with cancer that has spread (metastasized) and damaged the bone. Skeletal-related events include bone fractures from cancer and bone pain requiring radiation.

19 Nov 2010

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire all of the hemophilia-related assets of a privately-held biopharmaceutical company, Archemix, and entered into an exclusive license agreement for certain related intellectual property assets.

From Baxter International Inc. 19 Nov 2010

FibroGen to present FG-4592 phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia

FibroGen, Inc., today announced that new data from a phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia will be presented demonstrating that its first-in-class, investigational oral anemia therapy FG-4592 works differently than erythropoiesis stimulating agents (ESAs) to increase hemoglobin.

19 Nov 2010

Biorem third quarter gross profit decreases from $2,348,000 to $1,816,000

BIOREM Inc. today announced its results for the three-month period ended September 30, 2010. Biorem's complete 2010 third quarter financial statements and MD&A have been filed on SEDAR

19 Nov 2010

World Bank report examines member banks' response to global economic downturn, highlights effect on global poverty

By the end of this year, an additional 64 million people will fall into extreme poverty as a result of the global economic downturn that started in 2008, the World Bank said in a study on "member banks' response" to the situation, Reuters reports.

19 Nov 2010

Cyclacel to present results of sapacitabine Phase 2 trial for MDS at ASH Meeting

Cyclacel Pharmaceuticals, Inc. announced today that updated Phase 2 clinical trial results of sapacitabine for the treatment of myelodysplastic syndromes (MDS) will be presented at a poster presentation during the 52nd Annual Meeting of the American Society of Hematology (ASH) in Orlando, on Saturday, December 4, 2010.

19 Nov 2010

Liberator fourth fiscal quarter net revenue increases 51.5% from $7.586 million

Liberator Medical Holdings, Inc. today announced record net revenues of approximately $11.49 million for its fiscal fourth quarter ended September 30, 2010, and $40.92 million for the fiscal year ended September 30, 2010.

19 Nov 2010

Today's OpEds: Opposing views on hospital medical errors; lesson for Andy Harris; Dems and abortion

If a 747 jetliner crashed every day, killing all 500 people aboard, there would be a national uproar over aviation safety and an all-out mobilization to fix the problem. In the nation's hospitals, though, about the same number of people die on average every day from medical "adverse events," many of them preventable errors such as infections or incorrect medications.

19 Nov 2010

AARP urges Idaho to put families, children & elderly ahead of special interests when tackling budget woes

On the heels of grim news from Idaho's Joint Finance-Appropriation Committee regarding a $340 million shortfall that could mean deep cuts to critical programs and services, AARP is urging state lawmakers to refocus the looming debate to protect the education and health needs of Idaho's families, children and elderly. The Association is calling for lawmakers to get creative when it comes to possible sources of needed revenue to stave off possible cuts.

19 Nov 2010

AAO to recognize UH optometry dean with Charles F. Prentice Medal Award

Earl L. Smith III, O.D., dean of the College of Optometry and Greeman-Petty Professor at the University of Houston, is the 2010 recipient of the Charles F. Prentice Medal Award from the American Academy of Optometry.

19 Nov 2010

Task Force for National Conference on Diabetes issues Call to Action to improve diabetes care

The Task Force for the National Conference on Diabetes issued a Call to Action today entitled Shaping our future: a call to action to tackle the diabetes epidemic and reduce its economic impact. This Call to Action is a result of the National Conference on Diabetes, held earlier this year in Washington, D.C., which was attended by nearly 100 participants representing the Administration, Congress, government officials, public health organizations and industry.

19 Nov 2010

Boston Scientific's CRT-Ds, ICDs receive CE Mark approval

Boston Scientific Corporation today announced CE Mark approval of its INCEPTA, ENERGEN and PUNCTUA cardiac resynchronization therapy defibrillators and implantable cardioverter defibrillators.

19 Nov 2010

HHS, AARP to provide tips for seniors to stay healthy during flu season

Health and Human Services Secretary Kathleen Sebelius and Catherine Alicia Georges from AARP will lead an important webcast for seniors to discuss tips on how to stay healthy this flu season.

19 Nov 2010

Cold Spring releases new series of laboratory manuals

Sophisticated techniques that permit the visualization of dynamic processes in cells, tissues, and organ systems at extraordinary levels of resolution have become tremendously valuable in biological research. However, finding the right imaging method and optimizing it for data collection can be a daunting process, even for an established imaging laboratory. To fill this need, a new series of laboratory manuals has been developed by Cold Spring Harbor Laboratory Press. The first volume in this series, Imaging: A Laboratory Manual, has just been released.

19 Nov 2010

Medical News

Somaxon prices underwritten public offering of common stock

Medtronic's Valiant Stent System effective for thoracic aortic aneurysms treatment

State roundup: California PPOs 'low marks'; Geriatric nursing; Physician shortages

PSS World Medical enters definitive agreement to acquire Linear

Political cartoon: Mayberry R.F.D.?

U.S. falling short of its goals to improve access to clean water, sanitation worldwide, report says

Xgeva receives FDA approval for prevention of SREs in patients with bone metastases

Baxter enters definitive agreement to acquire all hemophilia-related assets Archemix

FibroGen to present FG-4592 phase 2a study of patients with stage 3-4 Chronic Kidney Disease and anemia

Biorem third quarter gross profit decreases from $2,348,000 to $1,816,000

World Bank report examines member banks' response to global economic downturn, highlights effect on global poverty

Cyclacel to present results of sapacitabine Phase 2 trial for MDS at ASH Meeting

Liberator fourth fiscal quarter net revenue increases 51.5% from $7.586 million

Today's OpEds: Opposing views on hospital medical errors; lesson for Andy Harris; Dems and abortion

AARP urges Idaho to put families, children & elderly ahead of special interests when tackling budget woes

AAO to recognize UH optometry dean with Charles F. Prentice Medal Award

Task Force for National Conference on Diabetes issues Call to Action to improve diabetes care

Boston Scientific's CRT-Ds, ICDs receive CE Mark approval

HHS, AARP to provide tips for seniors to stay healthy during flu season

Cold Spring releases new series of laboratory manuals

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News